AstraZeneca’s non-small lung cancer therapy gets FDA clearance
HQ Team February 17, 2024: The USFDA has cleared AstraZeneca’s Tagrisso with chemotherapy for treatment in adult patients with non-small cell lung cancer..
Drugs
Health
Pharma